Skip to main content
Erschienen in: European Radiology 5/2007

01.05.2007 | Magnetic Resonance

Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T

verfasst von: Marcus von Falkenhausen, Carsten Meyer, Götz Lutterbey, Nuschin Morakkabati, Oliver Walter, Jürgen Gieseke, Renate Blömer, Winfried A. Willinek, Christiane K. Kuhl, Hans H. Schild

Erschienen in: European Radiology | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

The purpose of the study was to examine if the higher susceptibility at 3.0 Tesla (T) compared to 1.5 T will affect the contrast in MR imaging of the liver after application of superparamagnetic iron oxide particles (SPIO). The study was approved by our institutional review board and informed consent was obtained. Seventeen healthy volunteers were examined in a prospective, intra-individual comparative study within one day on a 1.5 T and a 3.0 T MRI system. T2 weighted TSE sequences were acquired after bolus injection of a SPIO contrast agent. Image contrast and signal to noise ratio (SNR) were compared between the field strengths. Image contrast was calculated between the liver tissue and the kidneys / spleen / muscles and fluids. The students’T-test was used for statistical analysis. No influence of the higher field strength could be observed on image contrast except for the liver / muscle contrast. This was due to a distinct SNR increase of the muscle tissue at 3.0 T as a result of their relaxation properties. The higher susceptibility at 3.0 T compared to 1.5 T does not translate into a stronger signal attenuation of the SPIO enhanced liver parenchyma.
Literatur
2.
Zurück zum Zitat Nakada T (2003) Clinical experience on 3.0 T systems in Niigata, 1996 to 2002. Invest Radiol 38:377–384PubMedCrossRef Nakada T (2003) Clinical experience on 3.0 T systems in Niigata, 1996 to 2002. Invest Radiol 38:377–384PubMedCrossRef
3.
Zurück zum Zitat Kuhl CK, Textor J, Gieseke J et al (2005) Acute and subacute ischemic stroke at high-filed-strength (3.0-T) diffusion weighted MR imaging: intra individual comparative study. Radiology 234:509–516PubMedCrossRef Kuhl CK, Textor J, Gieseke J et al (2005) Acute and subacute ischemic stroke at high-filed-strength (3.0-T) diffusion weighted MR imaging: intra individual comparative study. Radiology 234:509–516PubMedCrossRef
4.
Zurück zum Zitat Willinek WA, Born M, Simon B et al (2003) Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging-initial experience. Radiology 229:913–920PubMedCrossRef Willinek WA, Born M, Simon B et al (2003) Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging-initial experience. Radiology 229:913–920PubMedCrossRef
5.
Zurück zum Zitat Frayne R, Goodyear BG, Dickhoff P et al (2003) Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38:385–402PubMedCrossRef Frayne R, Goodyear BG, Dickhoff P et al (2003) Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38:385–402PubMedCrossRef
6.
Zurück zum Zitat Morakkabati-Spitz N, Gieseke J, Kuhl C et al (2006) MRI of the pelvis at 3T: very high spatial resolution with sensitivity encoding and flip angle sweep technique in clinically acceptable scan time. Eur Radiol 16:634–641. DOI 10.1007/s00330-005-0016-1 PubMedCrossRef Morakkabati-Spitz N, Gieseke J, Kuhl C et al (2006) MRI of the pelvis at 3T: very high spatial resolution with sensitivity encoding and flip angle sweep technique in clinically acceptable scan time. Eur Radiol 16:634–641. DOI 10.​1007/​s00330-005-0016-1 PubMedCrossRef
7.
Zurück zum Zitat Stroszczynski C, Gaffke G, Gretschel S et al (2003) Use of SPIO-enhanced T1-and T2-weighted images for the differentiation of liver lesions: an ROC analysis. Fortschr Röntgenstr 175:1368–1375CrossRef Stroszczynski C, Gaffke G, Gretschel S et al (2003) Use of SPIO-enhanced T1-and T2-weighted images for the differentiation of liver lesions: an ROC analysis. Fortschr Röntgenstr 175:1368–1375CrossRef
8.
Zurück zum Zitat Reimer P, Jähnke N, Fiebich M et al (2000) Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217:152–158PubMed Reimer P, Jähnke N, Fiebich M et al (2000) Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217:152–158PubMed
9.
Zurück zum Zitat Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13:1266–1276. DOI 10.1007/s00330-002-1721-7 PubMed Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13:1266–1276. DOI 10.​1007/​s00330-002-1721-7 PubMed
11.
Zurück zum Zitat Reimer P, Tombach B (1998) Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 8:1198–1204PubMedCrossRef Reimer P, Tombach B (1998) Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 8:1198–1204PubMedCrossRef
12.
Zurück zum Zitat Shamsi K, Balzer T, Saini S et al (1998) Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.Radiology 206:365–371PubMed Shamsi K, Balzer T, Saini S et al (1998) Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.Radiology 206:365–371PubMed
13.
Zurück zum Zitat Balzer T, Carter EC, Shamsi K et al (1996) Results of a multicenter phase II clinical trial with a new susceptibility contrast medium for magnetic resonance imaging of the liver. Acad Radiol 3:Suppl 2:S417–419PubMedCrossRef Balzer T, Carter EC, Shamsi K et al (1996) Results of a multicenter phase II clinical trial with a new susceptibility contrast medium for magnetic resonance imaging of the liver. Acad Radiol 3:Suppl 2:S417–419PubMedCrossRef
14.
Zurück zum Zitat Neumann F, Cho CH, Spors B et al (2003) In vitro Vergleich der T2-Relaxivität von Eisenoxidpartikeln im MRT bei 1.5 und 3 Tesla. Fortschr Röntgenstr 175:S237 Neumann F, Cho CH, Spors B et al (2003) In vitro Vergleich der T2-Relaxivität von Eisenoxidpartikeln im MRT bei 1.5 und 3 Tesla. Fortschr Röntgenstr 175:S237
15.
Zurück zum Zitat De Bazelaire CMJ, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: Preliminary results. Radiology 230:652–659PubMedCrossRef De Bazelaire CMJ, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: Preliminary results. Radiology 230:652–659PubMedCrossRef
16.
Zurück zum Zitat Reimer P, Rummeny EJ, Daldrup HE et al (1995) Clinical results with Resovist: a phase 2 clinical trial. Radiology 195:489–496PubMed Reimer P, Rummeny EJ, Daldrup HE et al (1995) Clinical results with Resovist: a phase 2 clinical trial. Radiology 195:489–496PubMed
Metadaten
Titel
Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T
verfasst von
Marcus von Falkenhausen
Carsten Meyer
Götz Lutterbey
Nuschin Morakkabati
Oliver Walter
Jürgen Gieseke
Renate Blömer
Winfried A. Willinek
Christiane K. Kuhl
Hans H. Schild
Publikationsdatum
01.05.2007
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 5/2007
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-006-0484-y

Weitere Artikel der Ausgabe 5/2007

European Radiology 5/2007 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.